Pharmaceutical Business review

Gerresheimer reports rise in third quarter revenues

The company has posted a net income of EUR19.2m for the quarter, indicating a rise by 36% ascompared to the corresponding period of the previous year.

Adjusted earnings per share rose by 35% to EUR 0.70

Gerresheimer has posted adjusted EBITDA of EUR 57.1m in the third quarter of 2011, as compared to EUR53.3m in the prior year.